Fax: +44-115-962-7923.
1097-0215/asset/olbannerleft.jpg?v=1&s=45719cd7de57873027993264fcc568b335a8cd56)
1097-0215/asset/olbannerright.jpg?v=1&s=5e0fba63c1309b3036eb9215a0e1e83dd02efd19)
Fast Track
You have full text access to this OnlineOpen article
Immunosurveillance is active in colorectal cancer as downregulation but not complete loss of MHC class I expression correlates with a poor prognosis
Article first published online: 7 JUL 2005
DOI: 10.1002/ijc.21303
Copyright © 2005 Wiley-Liss, Inc.
Additional Information
How to Cite
Watson, N. F.S., Ramage, J. M., Madjd, Z., Spendlove, I., Ellis, I. O., Scholefield, J. H. and Durrant, L. G. (2006), Immunosurveillance is active in colorectal cancer as downregulation but not complete loss of MHC class I expression correlates with a poor prognosis. Int. J. Cancer, 118: 6–10. doi: 10.1002/ijc.21303
Publication History
- Issue published online: 26 OCT 2005
- Article first published online: 7 JUL 2005
- Manuscript Accepted: 6 MAY 2005
- Manuscript Received: 4 MAR 2005
- Abstract
- Article
- References
- Cited By
Cited in:
- CrossRef
This article has been cited by:
- 1, , , Monoclonal antibodies for the treatment of cancer, Seminars in Cancer Biology, 2012, 22, 1, 3
- 2, , , The bodies fight against cancer: is human leucocyte antigen (HLA) class 1 the key?, Journal of Cancer Research and Clinical Oncology, 2012, 138, 5, 723
- 3, , , , , Characterization of the immunological microenvironment of tumour buds and its impact on prognosis in mismatch repair-proficient and -deficient colorectal cancers, Histopathology, 2011, 59, 3Direct Link:
- 4, , , , , , , FoxP3- and CD8-positive Infiltrating Immune Cells Together Determine Clinical Outcome in Colorectal Cancer, Cancer Microenvironment, 2011,
- 5, , , , , , , , , The Stromal Overexpression of Decay Accelerating Factor (DAF/CD55) Correlates with Poor Clinical Outcome in Colorectal Cancer Patients, The Korean Journal of Pathology, 2011, 45, 5, 445
- 6, , , , Whole protein and defined CD8+ and CD4+ peptides linked to penetratin targets both MHC class I and II antigen presentation pathways, Immunology and Cell Biology, 2011, 89, 8, 904
- 7
- 8, , , “Hard” and “soft” lesions underlying the HLA class I alterations in cancer cells: Implications for immunotherapy, International Journal of Cancer, 2010, 127, 2Direct Link:
- 9, , , , , , Characterization of signaling function and expression of HLA class I molecules in medulloblastoma, Journal of Neuro-Oncology, 2010, 103, 2, 197
- 10, , , , , , , , , , Clinical and Immunologic Responses of HLA-A3+ Breast Cancer Patients Vaccinated with the HER2/neu-Derived Peptide Vaccine, E75, in a Phase I/II Clinical Trial, Journal of the American College of Surgeons, 2010, 210, 2, 140
- 11, , , , , , , , , , , Comparison of membrane fraction proteomic profiles of normal and cancerous human colorectal tissues with gel-assisted digestion and iTRAQ labeling mass spectrometry, FEBS Journal, 2010, 277, 14Direct Link:
- 12, , , , , , , , , , , , , , Down-regulation of the antigen processing machinery is linked to a loss of inflammatory response in colorectal cancer, Human Pathology, 2010, 41, 12, 1758
- 13
- 14, , , Immune evasion of microsatellite unstable colorectal cancers, International Journal of Cancer, 2010, 127, 5Direct Link:
- 15
- 16, , , , , , , , , , Inverse correlation of HER2 with MHC class I expression on oesophageal squamous cell carcinoma, British Journal of Cancer, 2010, 103, 4, 552
- 17, , , , Tumor Infiltrating Regulatory T Cells: Tractable Targets for Immunotherapy, International Reviews of Immunology, 2010, 29, 5, 461
- 18, , , , , , , , , Electroporation-mediated IL-12 gene therapy in a transplantable canine cancer model, International Journal of Cancer, 2009, 125, 3Direct Link:
- 19, , , , , , , , HLA and melanoma: multiple alterations in HLA class I and II expression in human melanoma cell lines from ESTDAB cell bank, Cancer Immunology, Immunotherapy, 2009, 58, 9, 1507
- You have free access to this content20, , , , , , , , , Human leukocyte antigen class I down-regulation in muscle-invasive bladder cancer: Its association with clinical characteristics and survival after cystectomy, Cancer Science, 2009, 100, 12Direct Link:
- 21, , , , , , Human leukocyte antigen class I expression is an independent prognostic factor in advanced ovarian cancer resistant to first-line platinum chemotherapy, British Journal of Cancer, 2009, 101, 8, 1321
- 22, , , Lung cancer-associated tumor antigens and the present status of immunotherapy against non-small-cell lung cancer, General Thoracic and Cardiovascular Surgery, 2009, 57, 9, 449
- 23, , , , , , , , , , , , , , , , , , , Reduced human leukocyte antigen expression in advanced-stage Ewing sarcoma: implications for immune recognition, The Journal of Pathology, 2009, 218, 2Direct Link:
- 24, , , , The HLA genomic loci map: expression, interaction, diversity and disease, Journal of Human Genetics, 2009, 54, 1, 15
- 25, , , , , , , , , Analysis of HLA class I expression in progressing and regressing metastatic melanoma lesions after immunotherapy, Immunogenetics, 2008, 60, 8, 439
- 26, , Defective MHC class I antigen surface expression promotes cellular survival through elevated ER stress and modulation of p53 function, Cell Death and Differentiation, 2008, 15, 9, 1364
- You have free access to this content27, , HOST RESPONSE TO COLORECTAL CANCER, ANZ Journal of Surgery, 2008, 78, 9Direct Link:
- 28, , , , , Potential Role of NK Cells in the Induction of Immune Responses: Implications for NK Cell–Based Immunotherapy for Cancers and Viral Infections, International Reviews of Immunology, 2008, 27, 3, 93
- 29, , , , , , Regressing and progressing metastatic lesions: resistance to immunotherapy is predetermined by irreversible HLA class I antigen alterations, Cancer Immunology, Immunotherapy, 2008, 57, 11, 1727
- 30, , , , , , , , , , Analysis of KIR gene frequencies in HLA class I characterised bladder, colorectal and laryngeal tumours, Tissue Antigens, 2007, 69, 3Direct Link:
- 31, , , , , Association of antigen processing machinery and HLA class I defects with clinicopathological outcome in cervical carcinoma, Cancer Immunology, Immunotherapy, 2007, 57, 2, 197
- 32, , , , , , , , , , , , , Beta2-microglobulin mutations in microsatellite unstable colorectal tumors, International Journal of Cancer, 2007, 121, 2Direct Link:
- 33, , , , , , , , , , , Clinical impact of HLA class I expression in rectal cancer, Cancer Immunology, Immunotherapy, 2007, 57, 5, 601
- 34, , , Dendritic cell vaccines for leukemia patients, Expert Review of Anticancer Therapy, 2007, 7, 3, 275
- 35, , , , , , , , , HLA class I antigen expression is associated with a favorable prognosis in early stage non-small cell lung cancer, Cancer Science, 2007, 98, 9Direct Link:
- 36, , , , , , , , , , HLA-A, -B, -C Expression in Colon Carcinoma Mimics That of the Normal Colonic Mucosa and is Prognostically Relevant, The American Journal of Surgical Pathology, 2007, 31, 1, 76
- 37, , , , , , , , , , Lack and restoration of sensitivity of lung cancer cells to cellular attack with special reference to expression of human leukocyte antigen class I and/or major histocompatibility complex class I chain related molecules A/B, Cancer Science, 2007, 98, 11Direct Link:
- 38, , , , Tumor immunoediting and immunosculpting pathways to cancer progression, Seminars in Cancer Biology, 2007, 17, 4, 275
- 39
- 40, , , , , Adoptive Transfer of Chimeric Fc ? RI Gene-Modified Human T Cells for Cancer Immunotherapy, Human Gene Therapy, 2006, 0, 0, 061019064400001
- 41, , , , , Adoptive Transfer of Chimeric FcεRI Receptor Gene-Modified Human T Cells for Cancer Immunotherapy, Human Gene Therapy, 2006, 17, 11, 1134
- 42, , , , , , , , , HLA class I expression in metastatic melanoma correlates with tumor development during autologous vaccination, Cancer Immunology, Immunotherapy, 2006, 56, 5, 709
- 43, , , , , , , , , , , , , Prognostic significance of HLA class I expression in osteosarcoma defined by anti-pan HLA class I monoclonal antibody, EMR8-5, Cancer Science, 2006, 97, 12Direct Link: